417 related articles for article (PubMed ID: 21739534)
1. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
[TBL] [Abstract][Full Text] [Related]
2. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
3. Most dysplasia in ulcerative colitis is visible at colonoscopy.
Rutter MD; Saunders BP; Wilkinson KH; Kamm MA; Williams CB; Forbes A
Gastrointest Endosc; 2004 Sep; 60(3):334-9. PubMed ID: 15332019
[TBL] [Abstract][Full Text] [Related]
4. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
[TBL] [Abstract][Full Text] [Related]
5. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
6. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital.
Kottachchi D; Yung D; Marshall JK
Can J Gastroenterol; 2009 Sep; 23(9):613-7. PubMed ID: 19816624
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.
Sugimoto S; Naganuma M; Iwao Y; Matsuoka K; Shimoda M; Mikami S; Mizuno S; Nakazato Y; Nanki K; Inoue N; Ogata H; Kanai T
Gastrointest Endosc; 2017 Mar; 85(3):639-646.e2. PubMed ID: 27884517
[TBL] [Abstract][Full Text] [Related]
8. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
9. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences.
van den Broek FJ; Stokkers PC; Reitsma JB; Boltjes RP; Ponsioen CY; Fockens P; Dekker E
Am J Gastroenterol; 2014 May; 109(5):715-22. PubMed ID: 21427710
[TBL] [Abstract][Full Text] [Related]
10. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
11. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
[TBL] [Abstract][Full Text] [Related]
12. Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U
Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
14. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
[TBL] [Abstract][Full Text] [Related]
15. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis.
Klepp P; Tollisen A; Røseth A; Cvancarova Småstuen M; Andersen SN; Vatn M; Moum BA; Brackmann S
World J Gastroenterol; 2018 Sep; 24(35):4069-4076. PubMed ID: 30254411
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.
Rozen P; Baratz M; Fefer F; Gilat T
Gastroenterology; 1995 May; 108(5):1361-70. PubMed ID: 7729627
[TBL] [Abstract][Full Text] [Related]
18. Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's Disease.
Lightner AL; Vogler S; McMichael J; Jia X; Regueiro M; Qazi T; Steele SR
J Crohns Colitis; 2021 Jan; 15(1):24-34. PubMed ID: 32592468
[TBL] [Abstract][Full Text] [Related]
19. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
20. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
